Childhood Cancer Awareness Month: 🎗️ THE SCIENCE BEHIND THE GOLD RIBBON: THE PERTSEMLIDIS LAB

September 11, 2026

Some of the most important instructions inside a cancer cell may come from genetic material that doesn’t make proteins at all. At the Greehey Children's Cancer Research Institute, the Pertsemlidis Lab, led by Alexander Pertsemlidis, PhD, combines computational biology, cancer biology and genetics to study molecules called non-coding RNAs—including microRNAs and long non-coding RNAs. Despite their name, these molecules are [...]

Childhood Cancer Awareness Month: 🎗️ THE SCIENCE BEHIND THE GOLD RIBBON: THE PENALVA LAB

September 10, 2026

What if we could stop an aggressive childhood brain tumor by disrupting the instructions it depends on to grow? At the Greehey Children’s Cancer Research Institute, the Penalva Lab, led by Luiz O.F. Penalva, PhD, studies RNA—the molecules that help cells decide when, where, and how genetic instructions are used. The lab is particularly interested [...]

Childhood Cancer Awareness Month: 🎗️ THE SCIENCE BEHIND THE GOLD RIBBON: THE LIBICH LAB

September 9, 2026

What if one of the biggest obstacles to treating a childhood cancer is that its main cancer-causing protein won’t hold still long enough to target it? That is part of the challenge facing researchers studying Ewing sarcoma, a rare and aggressive bone and soft-tissue cancer that primarily affects children and teenagers. At the Greehey Children's [...]

Childhood Cancer Awareness Month: THE SCIENCE BEHIND THE GOLD RIBBON: THE KITAGAWA LAB 🎗️

September 8, 2026

Cancer cells are notorious rule-breakers. Sometimes, they even end up with the wrong number of chromosomes. At the Greehey Children's Cancer Research Institute, the Kitagawa Lab, led by Katsumi Kitagawa, Pharm.D., PhD, is investigating how mistakes involving our chromosomes may contribute to childhood cancer. Normally, when a cell divides, it must copy and distribute its chromosomes with remarkable [...]

Childhood Cancer Awareness Month: THE SCIENCE BEHIND THE GOLD RIBBON: THE IGNATIUS LAB🎗️

September 4, 2026

Why do some childhood cancers return after treatment—and why can they be so much harder to treat the second time? At the Greehey Children’s Cancer Research Institute, the Ignatius Lab, led by Myron Ignatius, PhD, is working to answer those questions by studying rhabdomyosarcoma, the most common soft-tissue sarcoma in children. A tumor isn’t simply [...]

CHILDHOOD CANCER AWARENESS MONTH: 🎗️ The Science Behind the Gold Ribbon: Gupta Lab

September 3, 2026

What if researchers could see the machinery inside a cancer cell closely enough to figure out exactly how to disrupt it? At the Greehey Children’s Cancer Research Institute, the Gupta Lab, led by Yogesh K. Gupta, M.Tech, PhD, studies the molecular structures and processes that help cancer cells survive and grow. The lab focuses on sarcomas and leukemias, [...]

Childhood Cancer Awareness Month: THE SCIENCE BEHIND THE GOLD RIBBON: THE CHEN LAB🎗️

September 2, 2026

Cancer research generates an enormous amount of data. Hidden inside that data are clues that can help researchers better understand why childhood cancers develop, how they behave, and which treatments may work best. At the Greehey Children’s Cancer Research Institute, the Chen Lab, led by Yidong Chen, PhD, uses computational biology, bioinformatics and biostatistics to [...]

Childhood Cancer Awareness Month: 🎗️THE SCIENCE BEHIND THE GOLD RIBBON: THE AUNE LAB

September 1, 2026

Gregory J. Aune, MD, PhD, Surviving childhood cancer is the goal. But survival can come with consequences that last a lifetime. At the Greehey Children’s Cancer Research Institute, the Aune Lab, led by Gregory J. Aune, MD, PhD, studies the long-term health effects caused by the chemotherapy and radiation used to treat childhood cancer. Dr. [...]

Greehey CCRI Researcher Awarded Grant to Advance RNA-Based Therapy for Aggressive Pediatric Brain Cancer (Penalva)

June 11, 2026

Researchers at the Greehey Children's Cancer Research Institute (Greehey CCRI) at UT Health San Antonio continue to push the boundaries of pediatric cancer research with the support of a new grant awarded by the Pediatric Cancer Foundation. Luiz O. Penalva, PhD, has received funding for his project, "RNA Therapeutics to Target Aggressive Medulloblastoma," which aims [...]